… mice that received the treatment experienced fewer and less … have the potential to treat genetic neurological conditions beyond … editing to rescue a neurological disease. We looked at the … patients, and scientists that had developed around the disorder. Soon, …

… vice president, research and development and chief scientific officer, … s is a progressive neurological disorder caused by the death … no cure, there are treatments that can lessen symptoms, … drugs that reduce tremors. Most FDA-approved Parkinson’s medications …

… showing promise as a treatment beyond weight loss. ( … and weight-control medication liraglutide could sharply … drug repurposing. That’s where a drug developed for one disease ends up treating … a diabetes drug might now cure a common neurological disorder. It …

… microbiota in human neurological disorders has gained increasing … in the treatment of neurological disorders.13–15 … unreported in normal development, highlights disease-specific … Dehydroepiandrosterone (DHEA): pharmacological effects and potential therapeutic …

… .S. Food and Drug Administration (FDA) has granted Rare … the development of new drugs and biologics for the treatment … structures and pharmacological assessments to develop ART5803 as … managed, and often misdiagnosed neurological disease. ANRE is caused by …

… French institutions, have developed a tool that can … most commonly used drugs for treating multiple sclerosis. Despite … poor outcomes with natalizumab treatment are associated with … , inflammatory, and degenerative neurological disease that affects the central …

… can cause autism or other neurological disorders in children. The agency made … after the U.S. Federal Drug Administration (FDA) said there may be …

… gene therapies for the treatment of neurological disorders,” Dr. Walid Abi- … have a 50% chance of developing Huntington’s. The genetic … .com In the uniQure trial, 12 of 29 patients … symptoms can be managed through medications, physical, speech and occupational …

… SciSparc, this scrappy Israeli pharma player out of Tel Aviv … new drugs. Get it right, and you could unlock treatments for … could turbocharge drug hunts for tough nuts like neurological disorders and rare … but slow—years of trial and error, billions flushed …

… Hengrui, Harmony Biosciences’ trial setback for Zygel, and … Pharma for trastuzumab rezetecan, a next-generation antibody-drug … addressing unmet needs in neurological disorders but acknowledged the … reassessment of Zygel’s development path. Investors responded …